109327 ⎘
Active agents used in cell culture processes, e.g. differentation; Cytokines; Chemokines; Interleukins [IL] Interleukin-12 (IL-12)
NK-92 Cells with Cytokine Induced Memory-Like Cytotoxicity And Derivatives Thereof
#2NANOPARTICLES FOR DELIVERY OF IMMUNOREGULATORY MATERIALS TO T CELLS
#3ACTIVATION AND PROLIFERATION OF CYTOTOXIC LYMPHOCYTES
#4A METHOD OF PRODUCING INNATE LYMPHOID CELLS FOR USE IN THERAPY
#5COMPOSITIONS AND METHODS RELATED TO POTENT CYTOTOXIC M-CENK CELLS FROM CD3/CD14-DEPLETED APHERESIS PRODUCTS
#6GENERATION OF CTL LINES WITH SPECIFICITY AGAINST MULTIPLE TUMOR ANTIGENS OR MULTIPLE VIRUSES
#7COMPOSITIONS AND METHODS FOR NK CELL DIFFERENTIATION
#8SELECTION OF OPTIMAL CELL DONORS AND METHODS AND COMPOSITIONS FOR ENHANCED EXPANSION AND CYTOTOXICITY OF DONOR CELLS
#9METHODS TO GENERATE ENHANCED TUMOR INFILTRATING LYMPHOCYTES THROUGH MICROFLUIDIC DELIVERY
#10ENGINEERED PROGENITOR CELLS AND METHODS OF USE
#11REGULATORY T CELL STABILITY ASSAY
#12CRYOPRESERVATION OF NK CELL PRODUCTS FOR OFF-THE-SHELF IMMUNOTHERAPY
#13CELLULAR MICROCOMPARTMENTS COMPRISING LYMPHOCYTES FORMING A 3D GROUPED CULTURE AND HAVING A LOW GRANZYME B CONTENT
#14METHODS FOR ACTIVATION AND EXPANSION OF ENGINEERED NATURAL KILLER CELLS AND COMBINATIONS WITH ANTIBODIES
#15CELLULAR MICROCOMPARTMENTS COMPRISING LYMPHOCYTES FORMING A GROUPED 3D CULTURE AND HAVING A LOW TNF ALPHA CONTENT
#16PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST HEAD AND NECK SQUAMOUS CELL CARCINOMA AND OTHER CANCERS
#17COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES
#18THERAPIES WITH LANTHIONINE C-LIKE PROTEIN 2 LIGANDS AND CELLS PREPARED THEREWITH
#19STAGED CULTURE METHOD FOR IN-VITRO EXPANSION OF HUMAN CYTOKINE-INDUCED KILLER (CIK) AND USE THEREOF
#20NOVEL DUAL CULTURE METHOD FOR CULTURING IMMUNE CELLS AND NATURAL KILLER CELLS, AND USE THEREOF
#21Methods for Activation and Expansion of T Cells
#22METHODS AND COMPOSITIONS HIGH SCALE THERAPEUTIC PRODUCTION OF MEMORY NK CELLS
#23METHOD FOR PRODUCING MEMORY-LIKE NATURAL KILLER CELLS AND ANTICANCER USE OF MEMORY-LIKE NATURAL KILLER CELLS PRODUCED THEREBY
#24COMPOSITION FOR CULTRING NK CELLS, COMPRISING ALLOFERON, AND METHOD FOR CULTURING NK CELLS USING SAME
#25COMPOSITIONS AND METHODS FOR EXPANDING EX VIVO NATURAL KILLER CELLS AND THERAPEUTIC USES THEREOF
#26TRANSGENIC T CELL RECEPTORS TARGETING NEOANTIGENS FOR DIAGNOSIS, PREVENTION, AND/OR TREATMENT OF HEMATOLOGICAL CANCERS
#27METHODS FOR EXPANDING T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES
#28COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC T CELL EXPANSION
#29IMMUNE CELL POPULATIONS AND USES THEREOF
#30ANTIBODY LOADED IMMUNE CELLS AND METHODS FOR USE IN CANCER TREATMENT
#31EXPANSION OF MEMORY NATURAL KILLER CELLS
#32TUMOR INFILTRATION LYMPHOCYTE CULTURE MEDIUM AND APPLICATION THEREOF
#33GENERATION OF T CELL LINES WITH SPECIFICITY AGAINST ONE OR MORE NEOANTIGENS
#34ENGINEERED NATURAL KILLER (NK) CELLS AND RELATED METHODS
#35METHOD FOR PRODUCING CD8alpha+beta+ CYTOTOXIC T CELLS
#36PHARMACEUTICAL COMPOSITION COMPRISING MODIFIED NATURAL KILLER CELLS AND ANTIGEN-SPECIFIC T CELLS, MANUFACTURING METHOD THEREOF, AND METHOD OF USING THE SAME
#37Highly Potent M-CENK Cells And Methods
#38MODULATED IMMUNODOMINANCE THERAPY
#39METHODS FOR ACTIVATION AND EXPANSION OF NATURAL KILLER CELLS AND COMBINATIONS WITH BISPECIFIC ANTIBODIES
#40METHOD FOR ACTIVATING T CELLS FOR CANCER TREATMENT
#41Highly Potent M-CENK Cells And Methods
#42CD38-NAD+ REGULATED METABOLIC AXIS IN ANTI-TUMOR IMMUNOTHERAPY
#43MODULATION OF A PATHOGENIC PHENOTYPE IN TH1 CELLS
#44METHOD FOR T-CELL EXPANSION AND RELATED MEDICAL APPLICATIONS
#45NANOPARTICLE-MEDIATED IMMUNE CELL MANUFACTURE AND USE THEREOF
#46STIMULATION OF OVARIAN FUNCTION SUBSEQUENT TO CHEMOTHERAPY AND/OR RADIATION THERAPY USING NATURAL KILLER CELLS
#47GENERATION OF CTL LINES WITH SPECIFICITY AGAINST MULTIPLE TUMOR ANTIGENS OR MULTIPLE VIRUSES
#48STEM CELL-LIKE MEMORY T CELLS AND USES THEREOF
#49METHOD FOR PRODUCING TUMOR-INFILTRATING T-LYMPHOCYTES (TIL) AND THEIR USE AS CELLULAR THERAPEUTICS FOR THE TREATMENT OF HUMAN TUMORS
#50ENHANCED EXPANSION AND CYTOTOXICITY OF ENGINEERED NATURAL KILLER CELLS AND USES THEREOF
#51EXPANSION OF GAMMA DELTA T CELLS, COMPOSITIONS, AND METHODS OF USE THEREOF
#52SEED CELL MEDIUM OF TUMOR-INFILTRATING LYMPHOCYTE AND APPLICATION THEREOF
#53IMMUNOTHERAPY FOR POLYOMAVIRUSES
#54FEEDER FREE CELL CULTURE METHODS FOR EXPANDING NATURAL KILLER CELL PREPARATIONS
#55GENERATION OF CTL LINES WITH SPECIFICITY AGAINST MULTIPLE TUMOR ANTIGENS OR MULTIPLE VIRUSES
#56A MIXTURE OF MRNA TO ENHANCE THE POTENCY OF DENDRITIC CELLS
#57TUMOR-INFILTRATING LYMPHOCYTES WITH ENHANCED TUMOR REACTIVITY
#58Natural Killer Cells for Treatment of Coronavirus Infection
#59METHODS OF PRODUCING T CELL POPULATIONS USING INDUCED PLURIPOTENT STEM CELLS
#60METHODS FOR EXPANDING GAMMA DELTA T-CELL POPULATIONS WITH MULTIVALENT AGENTS AND COMPOSITIONS THEREOF
#61METHODS AND COMPOSITIONS FOR ENHANCED EXPANSION AND CYTOTOXICITY OF NATURAL KILLER CELLS
#62LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING OF T CELLS
#63TUMOUR INFILTRATING LYMPHOCYTE THERAPY AND USES THEREOF
#64Method for ex vivo expansion CD34+HSPCs into NK cells using an aryl hydrocarbon receptor antagonist
#65COMPOSITION FOR CULTURING PERIPHERAL BLOOD MONOCYTE-DERIVED REGULATORY T CELL AND REGULATORY T CELL CULTURING METHOD USING SAME
#66Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
#67Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
#68GENERATION OF CTL LINES WITH SPECIFICITY AGAINST MULTIPLE TUMOR ANTIGENS OR MULTIPLE VIRUSES
#69METHODS OF ISOLATING T CELL POPULATIONS
#70METHODS FOR EXPANDING T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES
#71PDL1 POSITIVE NK CELL CANCER TREATMENT
#72METHOD FOR PRODUCING CAR GENE-INTRODUCED NK CELLS AND USE THEREOF
#73Genetically Engineered Cells and Uses Thereof
#74ADDITIVE COMPOSITION FOR NK CELL CULTURE MEDIUM, CULTURE METHOD FOR NK CELL BY USING SAME ADDITIVE COMPOSITION, AND COSMETICS COMPOSITION OBTAINED THEREBY FOR IMPROVING SKIN PROBLEMS
#75COMPOSITION, CULTURE MEDIUM AND METHOD FOR INDUCING AND/OR AMPLIFYING TSCM IN VITRO
#76METHOD FOR PRODUCING IMMUNOCYTES, AND USE THEREOF
#77CRYOPRESERVATION AND CELL CULTURE MEDIA
#78Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith
#79MEDIA AND METHODS FOR DIFFERENTIATING NATURAL KILLER CELLS
#80IMMUNE CELL FUNCTION
#81METHODS FOR THE SIMULTANEOUS EXPANSION OF MULTIPLE IMMUNE CELL TYPES, RELATED COMPOSITIONS AND USES OF SAME IN CANCER IMMUNOTHERAPY
#82Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
#83Compositions and methods for immune cell modulation in adoptive immunotherapies
#84METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER AND INFECTIOUS DISEASES
#85CIML NK cells and Methods Therefor
#86Kit containing medium for culturing natural killer cells and method of effectively culturing natural killer cells using the same
#87METHOD FOR PRODUCING CD3-POSITIVE CELL
#88METHODS OF USING LYSINE DEACETYLASE (KDAC) INHIBITION TO GENERATE ANTIGEN SPECIFIC MEMORY T CELL RESPONSES FOR DURABLE IMMUNOTHERAPY
#89METHOD FOR PRODUCING MEMORY-LIKE NK CELLS WITH ABILITY TO EXPRESS HIGHER LEVELS OF NCRS, CYTOTOXICITY, AND IFN-y THAN NK CELLS IN HUMAN PERIPHERAL BLOOD
#90Modified natural killer cells, pharmaceutical composition, manufacturing method thereof, and method of using the same
#91Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
#92USE OF IL-12 TO ALTER EPIGENETIC EFFECTOR PROGRAMS IN CD8 T CELLS
#93GENERATION OF KNOCK-OUT PRIMARY AND EXPANDED HUMAN NK CELLS USING CAS9 RIBONUCLEOPROTEINS
#94COMPOSITIONS CONTAINING A CELL PRODUCT COMPRISING AN EXPANDED AND ENRICHED POPULATION OF SUPERACTIVATED CYTOKINE KILLER T CELLS AND METHODS FOR MAKING SAME
#95METHOD FOR PRODUCING NATURAL KILLER CELLS
#96Methods and compounds for improved immune cell therapy
#97METHODS AND COMPOSITIONS FOR TH9 CELL MEDIATED CANCER TREATMENT
#98Expansion of γδ T cells, compositions, and methods of use thereof
#99ACTIVE CXCR4+ IMMUNE CELLS AND METHODS FOR THEIR PRODUCTION AND USE
#100Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
#101EX VIVO NK CELL DIFFERENTIATION FROM CD34+ HEMATOPOIETIC CELLS
#102METHODS FOR MANUFACTURING T CELLS
#103Method for activating T cells for cancer treatment
#104CIML NK cells and Methods Therefor
#105CIML NK cells and Methods Therefor
#106Natural killer cells with enhanced viability, proliferation and cytotoxicity following cryopreservation
#107Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
#108Method for activating T cells for cancer treatment
#109METHODS OF EXPANDING AND ASSESSING B CELLS AND USING EXPANDED B CELLS TO TREAT DISEASE
#110Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
#111Methods for selectively expanding cells expressing a TCR with a murine constant region
#112Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
#113Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
#114Methods and materials for producing T cells
#115Compositions for expanding natural killer cells
#116Reversing the effects of the tumor microenvironment using chimeric cytokine receptors
#117COMPOSITIONS CONTAINING A CELL PRODUCT COMPRISING AN EXPANDED AND ENRICHED POPULATION OF SUPERACTIVATED CYTOKINE KILLER T CELLS AND METHODS FOR MAKING SAME
#118Indole regulation of antigen presenting cells
#119Method for producing B cell population and method for producing monoclonal antibody using same
#120METHOD FOR IN VITRO ACTIVATION OF IMMUNE CELLS
#121IMMUNE CELL COMPOSITIONS AND METHODS OF USE
#122Systems and methods for immunomodulation of mucosal-associated invariant T cells
#123Method for producing CD8alpha+beta+ cytotoxic t cells
#124Method for inducing amplification of type I NKT cells in vitro
#125METHODS AND COMPOSITIONS HIGH SCALE THERAPEUTIC PRODUCTION OF MEMORY NK CELLS
#126METHOD OF CULTURING IMMUNE CELLS, KIT FOR THEREOF, IMMUNE CELL CULTURED MEDIUM OBTAINED BY SAME METHOD, COSMETIC COMPOSITION AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF
#127GENERATION OF CTL LINES WITH SPECIFICITY AGAINST MULTIPLE TUMOR ANTIGENS OR MULTIPLE VIRUSES
#128CD38-NAD+ regulated metabolic axis in anti-tumor immunotherapy
#129Methods for manufacturing T cells
#130Generation of HPV-specific T-cells
#131In vitro neonatal biomimetic (nMIMIC) model and methods of using same
#132Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith
#133GENERATION OF CTL LINES WITH SPECIFICITY AGAINST MULTIPLE TUMOR ANTIGENS OR MULTIPLE VIRUSES
#134Compositions and methods for immune cell modulation in adoptive immunotherapies
#135Bovine serum composition and method for culturing cells using said bovine serum composition as additive
#136Regulatory T-cells, method for their isolation and uses
#137Selection methods for genetically-modified T cells
#138Semi-static cell culture
#139Methods of expanding and assessing B cells and using expanded B cells to treat disease
#140Generation of HPV-specific T-cells
#141Improved method for ex vivo expansion CD34+HSPCs into NK cells using an aryl hydrocarbon receptor antagonist
#142Methods and materials for producing T cells
#143Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
#144METHODS OF OBTAINING MONONUCLEAR BLOOD CELLS AND USES THEREOF
#145Methods for high scale therapeutic production of memory NK cells
#146Ex vivo NK cell differentiation from CD34 hematopoietic cells
#147IL-9 SECRETING CD8+ Tc9 CELLS AND METHOD OF TREATING CANCER
#148Active CXCR4+ immune cells and methods for their production and use
#149CULTURE MEDIUM AND METHOD FOR ENRICHING AND MAINTAINING CANCER STEM CELLS (CSCS) USING SAID MEDIUM
#150Modulated immunodominance therapy
#151MODULATED IMMUNODOMINANCE THERAPY
#152NKT-like cell subpopulation and method of using the same in the treatment of tumor
#153Generation of CTL lines with specificity against multiple tumor antigens or multiple viruses
#154Cell expansion
#155Modified natural killer cells, compositions and uses thereof
#156Formulation and method for preparing specific T cell, and method for preparing the formulation
#157ENDOGENOUS VACCINE FOR CANCER AND INFECTIOUS DISEASES
#158Method for treating cancers with dendritic killer cells and pharmaceutical composition comprising the same
#159Generation of broadly-specific, virus-immune cells targeting multiple HIV antigens for preventive and therapeutic use
#160RNA preparations comprising purified modified RNA for reprogramming cells
#161IL-9 secreting CD8+ Tc9 cells and methods of treating cancer
#162Method for obtaining monocytes or NK cells
#163Methods of producing and using regulatory B-cells
#164EX VIVO NK CELL DIFFERENTIATION FROM CD34+ HEMATOPOIETIC CELLS
#165CD4+ CD25+ T-CELLS ACTIVATED TO A SPECIFIC ANTIGEN
#166Methods of expanding and assessing B cells and using expanded B cells to treat disease
#167Uses of IL-12 and the IL-12 receptor positive cell in tissue repair and regeneration
#168Methods of treatment using ex vivo expansion of cord blood T cells
#169COMPOSITIONS AND METHODS OF ALTERATION OF AUTOIMMUNE DISEASES
#170Generation of CTL lines with specificity against multiple tumor antigens or multiple viruses
#171Cd4+ Cd25+ T-cells activated to a specific antigen